Curative Proton Beam Therapy for Patients With Lung Metastasis of Colorectal Cancer
NCT03566355 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36
Last updated 2019-08-21
Summary
Proton alone therapy is performed
-\> 5 times a week, 7200 cGy / 15 fractions for 3 weeks total
Conditions
Interventions
- RADIATION
-
curative proton therapy
Patients who meet the selection criteria are selected, signed for consent, and treated with proton therapy alone at 7200 cGy / 15 fractions, 5 times a week for 3 weeks
Sponsors & Collaborators
-
National Cancer Center, Korea
lead OTHER_GOV
Principal Investigators
-
Dae Yong Kim, M.D. · National Cancer Center Korea(South Korea)
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-05-23
- Primary Completion
- 2025-12-31
- Completion
- 2025-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Study of Respiratory Gated Proton Beam Radiotherapy for Inoperable Pancreas Carcinoma
NCT00658801 ·Status: TERMINATED ·Phase: PHASE1
-
Short Course Radiotherapy Followed Intensive Chemotherapy With Delayed Surgery for Rectal Cancer With Synchronous Distant Metastasis
NCT01923987 ·Status: UNKNOWN ·Phase: PHASE2
-
Short-term and Long-term Outcomes of Colorectal Cancer Treated With Natural Orifice Specimen Extraction Surgery : a National Registry-based Study
NCT06350370 ·Status: RECRUITING ·Phase: NA
-
Short Course Radiotherapy, Unresectable Rectal Cancer, Liver Metastasis
NCT03022734 ·Status: UNKNOWN ·Phase: PHASE2
-
Neoantigen-based Peptide Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment
NCT06751966 ·Status: RECRUITING ·Phase: NA
-
Neoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment
NCT06751914 ·Status: RECRUITING ·Phase: NA
-
Computed Tomography-guided Brachytherapy Plus Chemotherapy for Locally Recurrent Rectum Cancer
NCT02423226 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Different Treatment for Anorectal Function of Patients With Rectal Cancer
NCT05671809 ·Status: NOT_YET_RECRUITING
-
Delayed Systemic Therapy Following Destructive Local Treatment of Pulmonary Oligometastases After No Evidence of Disease (NED) in Colorectal Cancer.
NCT06778382 ·Status: RECRUITING ·Phase: PHASE2
-
Using 4D Urinary Proteomics to Predict and Evaluate Treatment Response in Colorectal Cancer
NCT06904677 ·Status: RECRUITING
-
Re-irradiation Therapy of Locally Recurrent Rectal Cancer With Carbon Ion
NCT05807984 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Multicenter Cohort Prospective Study on Multidisciplinary Treatment of Rectal Cancer
NCT01651026 ·Status: UNKNOWN
-
CGA Guided Ultrafractionated RT and Systemic Treatment in Elderly or Frail Patients with Inoperable Localized CRC
NCT06652412 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Stereotactic Body Radiotherapy for Oligometastases From Colorectal Cancer
NCT02909114 ·Status: UNKNOWN ·Phase: PHASE2
-
Consolidative Radiotherapy Plus Maintenance Chemotherapy for Metastatic Colorectal Cancer
NCT03142282 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical Outcomes of Treatment With Immunomodulator Plus Cancer Therapies for Patients With Colorectal Cancer
NCT06557668 ·Status: RECRUITING
-
The Role of 18F-FDG and 68Ga-FAPI PET/CT in the Diagnosis and the Efficacy Evaluation of Advanced Colorectal Cancer (peritoneal Metastasis With/without Other Metastases)
NCT06601075 ·Status: RECRUITING
-
Effective Study of Preoperative Short-course Radiotherapy for the Advanced Resectable Rectal Cancer
NCT01437514 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety Study of DC-CIK Cell Therapy Combined With Epaloliposide, Vortexil, and Regorafenib as Third-line Treatment for Advanced Colorectal Cancer.
NCT07343791 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Local Consolidative Therapy in Colorectal Cancer
NCT05062720 ·Status: WITHDRAWN ·Phase: PHASE2
-
Short-course Preoperative Chemoradiotherapy for Rectal Cancer
NCT01431599 ·Status: UNKNOWN ·Phase: PHASE2
-
SCRT + mFOLFOX6 + PD-1 Antibody + Targeted Therapy for HIgh-Risk pMMR/MSS Rectal Cancer
NCT06908031 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Short Course Radiation Therapy for Elderly Patients With Rectal Cancer
NCT04139967 ·Status: TERMINATED ·Phase: NA
-
Preoperative Radiotherapy and E7046 in Rectum Cancer
NCT03152370 ·Status: COMPLETED ·Phase: PHASE1
-
PET-CT and Circulating Tumor Cells in Colorectal Cancer
NCT01163305 ·Status: COMPLETED